Quest Diagnostics (DGX) Adds $1B to Buyback Plan
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $237.14 -0.94%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
Revenue Growth %: +7.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
Revenue Growth %: +7.8%
Join SI Premium – FREE
Quest Diagnostics Incorporated (NYSE: DGX),announced that its Board of Directors increased the company's share repurchase authorization by $1 billion. This action increases the current share repurchase authorization to $1.1 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bilibili prices $700M convertible notes with Tencent participation
- Kontoor Brands sets Helly Hansen revenue target above $1.1B by 2030
- Alerus Financial raises dividend, approves new buyback program
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
